Hints and tips:
Related Special Reports
...More than 1,000 A&O lawyers are already using the tool, with five unnamed clients from banking, pharma, technology, media and private equity signed up to use the platform from January....
...Novo bulks up to boost sales of weight-loss drugs The Danish pharma giant Novo Nordisk has become Europe’s most valuable corporation by making drugs that help people lose weight....
...And Hannah points out that this is a distinct ownership structure for a pharma company. Hannah Kuchler It is a common structure in Denmark. But in the pharma industry, it is unusual....
...Private equity firms face worst year for exiting investments in a decade (FT) How China’s property crisis has unfolded, from Evergrande to Country Garden (FT) International Flavors mulls $3.5bn sale of pharma...
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...UK pharma group GSK has spun off Haleon on the basis that there is limited overlap between selling Advil and developing HIV vaccines....
...Both the tech and pharma industries are now structured in this way: small and innovative start-ups build new products in the hope of being bought by large platforms....
...Gilead SciencesO: 6; L: 8; I: 7; Total: 21The South Korean legal team at the US-based pharma group increased self-service on legal issues in the rest of the business....
...The pharma industry has high hopes for the new class of drugs being developed to treat Alzheimer’s....
...Coffee chain Starbucks, automaker Ford, cleaning goods producer Clorox, and Rupert Murdoch’s News Corp media group release earnings after the market closes....
...Ireland is heavily dependent on big tech and pharma multinationals, which make up more than half of corporate tax revenues....
...The head of pharma company Sanofi said UK economic policy meant the country was falling behind in healthcare innovation....
...“We utterly disagree with the CMA’s ruling that Advanz Pharma’s affiliate, Focus Pharmaceuticals Limited, infringed competition law by allegedly being party to ‘pay for delay’ and/or market-sharing arrangements...
...Arrival is merging with Kensington Capital Acquisition Corp V, paying a huge premium in order to add $300mn to its balance sheet. It is a desperate move that is unlikely to trigger a Spac revival....
...Privately held Viterra’s other shareholders are the Canada Pension Plan Investment Board and British Columbia Investment Management Corp....
...This nascent healthcare group would quickly establish itself as go-to advisers to various big pharma clients including Pfizer....
...The stocks of vaccine makers China National Medicines Corp, CanSino Biologics and Walvax Biotechnology remained flat....
...News round-up Pharma and biotech seek cure for industry deal slump (FT) TIM’s top shareholder Vivendi leaves board seat (Reuters) Big Four accountants in Spain probed over long hours (FT) Bain Capital...
...Fox: Investors will be on the lookout for more details about plans for the potential reunification of Fox and News Corp, parent of the Wall Street Journal, under one company....
...Nevertheless, the so-called killer merger — a company taking out a rival solely to extinguish its threat — seems a lot rarer in tech than in industries such as pharma....
...Similarly, bank and pharma share prices have trailed some spectacular earnings rebounds....
...In its latest assault on Big Pharma, the Competition and Markets Authority said Advanz and the buyout groups, which owned businesses that are now part of the pharma company, had charged “excessive and unfair...
...Advanz said in a statement: “We strongly disagree with the CMA’s decision and will be appealing....
...It’s the biggest pharma deal since AstraZeneca bought Alexion for $39bn last year and signalled a resurgence of activity in the sector....
...Both private equity firms used to own businesses that are now part of the drugs company Advanz Pharma — which has been through a series of buyouts and a restructuring since 2009 and was just last month bought...
International Edition